BR112012018772A2 - composto, composição farmacêutica e uso de um composto - Google Patents

composto, composição farmacêutica e uso de um composto

Info

Publication number: BR112012018772A2
Authority: BR; Brazil
Prior art keywords: compound; pharmaceutical composition; pharmaceutical; composition
Prior art date: 2010-01-29

Application number

BR112012018772A

Other languages

English (en)

Inventor

Andreas Kubin

Daniela Schuster

Gerhard Wolber

Paul Furtmüller

Original Assignee

Inoxia Lifesciences Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2010-01-29

Filing date

2011-01-28

Publication date

2016-04-12

2011-01-28 Application filed by Inoxia Lifesciences Gmbh filed Critical Inoxia Lifesciences Gmbh

2016-04-12 Publication of BR112012018772A2 publication Critical patent/BR112012018772A2/pt

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/34—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Virology (AREA)
Emergency Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Pain & Pain Management (AREA)
Communicable Diseases (AREA)
Rheumatology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Oncology (AREA)
Otolaryngology (AREA)
Dermatology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

BR112012018772A 2010-01-29 2011-01-28 composto, composição farmacêutica e uso de um composto BR112012018772A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
AT0012210A AT509045B1 (de)	2010-01-29	2010-01-29	Verbindungen zur behandlung von asthma bronchiale
PCT/AT2011/000050 WO2011091461A1 (de)	2010-01-29	2011-01-28	Verbindungen zur verwendung bei der behandlung von erkrankungen

Publications (1)

Publication Number	Publication Date
BR112012018772A2 true BR112012018772A2 (pt)	2016-04-12

Family

ID=43707937

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BR112012018772A BR112012018772A2 (pt)	2010-01-29	2011-01-28	composto, composição farmacêutica e uso de um composto

Country Status (12)

Country	Link
US (1)	US20130065962A1 (pt)
EP (2)	EP2965755A1 (pt)
JP (1)	JP5788907B2 (pt)
KR (1)	KR20120128644A (pt)
CN (2)	CN104958286B (pt)
AT (1)	AT509045B1 (pt)
AU (1)	AU2011208939B2 (pt)
BR (1)	BR112012018772A2 (pt)
CA (1)	CA2788326A1 (pt)
MX (1)	MX2012008815A (pt)
SG (1)	SG182786A1 (pt)
WO (1)	WO2011091461A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20150237857A1 (en) *	2012-08-10	2015-08-27	Mcmaster University	Antibacterial inhibitors
TWI689490B (zh)	2013-03-15	2020-04-01	英商邊緣生物科技有限公司	用於治療纖維化之經取代之芳族化合物及相關方法
AU2015330643B2 (en) *	2014-10-10	2020-05-14	Liminal Biosciences Limited	Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of diabetes
EP3323428A1 (en) *	2016-11-17	2018-05-23	CNRS Centre National de la Recherche Scientifique	Selective c-flip inhibitors as anticancer agents
CN117062898A (zh) *	2021-03-31	2023-11-14	雪佛龙奥伦耐有限责任公司	用于减轻低速早燃事件的组合物

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4082846A (en)	1976-11-18	1978-04-04	University Of Utah	Method for treating psoriasis
EP0323590A3 (en)	1987-12-24	1990-05-02	Ono Pharmaceutical Co., Ltd.	Carbazoyl derivatives
JPH02753A (ja) *	1987-12-24	1990-01-05	Ono Pharmaceut Co Ltd	カルバゾイル誘導体、それらの製造方法およびそれらを有効成分として含有するメイラード反応阻害剤
ES2104938T3 (es)	1991-04-01	1997-10-16	Univ Duke	Metodo de inhibir la fibrosis.
US5324747A (en) *	1992-07-15	1994-06-28	Hoffmann-La Roche Inc.	N-substituted anilines, inhibitors of phospholipases A2
CH683965A5 (it) *	1993-02-19	1994-06-30	Limad Marketing Exp & Imp	Composti della classe dei ftalidrazidici come sostanza attiva in agenti antinfiammatori ed antitossici.
US6011000A (en) *	1995-03-03	2000-01-04	Perrine; Susan P.	Compositions for the treatment of blood disorders
US6197743B1 (en) *	1996-07-26	2001-03-06	The Trustees Of Boston University	Compositions and methods for the treatment of viral disorders
US5741926A (en) *	1997-02-12	1998-04-21	Shaman Pharmaceuticals, Inc.	Aniline derivatives having antihyperglycemic activity
US6294350B1 (en)	1997-06-05	2001-09-25	Dalhousie University	Methods for treating fibroproliferative diseases
CA2324426A1 (en) *	1998-02-11	1999-08-19	Douglas V. Faller	Compositions and methods for the treatment of cystic fibrosis
JP2002524505A (ja) *	1998-09-15	2002-08-06	コリアリサーチインスティチュートオブバイオサイエンスアンドバイオテクノロジー	高血中脂質濃度に因る疾患の予防または治療のための、ケイ皮酸誘導体を含む組成物
AU2004242565A1 (en) *	1999-01-12	2005-01-27	Kenneth Blum	Treatment of hypertension with compounds that inhibit the destruction of enkephalins or endorphins
AU758207B2 (en)	1999-05-28	2003-03-20	Cj Cheiljedang Corporation	Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same
IT1313567B1 (it) *	1999-07-27	2002-09-09	Zambon Spa	Uso della n-acetil-cisteina per la preparazione di composizionifarmaceutiche topiche per il trattamento di patologie allergiche delle
US6444829B1 (en)	2000-07-19	2002-09-03	Hoffmann-La Roche Inc.	Pyrrolidine compounds
KR20040105853A (ko)	2002-04-08	2004-12-16	토렌트 파마슈티칼스 리미티드	티아졸리딘-4-카르보니트릴 및 유사체와디펩티딜-펩티다아제 억제제로서의 용도
EP1603858A2 (en)	2003-03-11	2005-12-14	NeuroSearch A/S	Kcnq channel modulating compounds and their pharmaceutical use
WO2005085185A1 (en)	2004-03-03	2005-09-15	Smithkline Beecham Corporation	Aniline derivatives as selective androgen receptor modulators
DE102004028862A1 (de)	2004-06-15	2005-12-29	Merck Patent Gmbh	3-Aminoindazole
CN1686297A (zh) *	2005-04-07	2005-10-26	甘肃圣达医药科技有限责任公司	一种止咳平喘药物及其制备方法
CU23431B6 (es) *	2005-05-12	2009-10-16	Ct Ingenieria Genetica Biotech	Método para la inhibición de la proliferación de células tumorales y el tratamiento del cáncer
WO2007026215A1 (en)	2005-08-29	2007-03-08	Glenmark Pharmaceuticals S.A.	Pyrazole derivatives as cannabinoid receptor ligands, pharmaceutical compositions containing? them, and processes for their preparation
DE102006005179A1 (de)	2006-02-06	2007-08-09	Merck Patent Gmbh	Aminoindazolderivate
US7956064B2 (en) *	2006-09-01	2011-06-07	Cylene Pharmaceuticals, Inc.	Fused tricyclic compounds as serine-threonine protein kinase and PARP modulators
DK2142516T3 (da)	2007-03-30	2013-04-15	Sanofi Sa	Pyrimidinhydrazidforbindelser i ders egenskab af pgds-inhibitorer
TWI490214B (zh)	2008-05-30	2015-07-01	艾德克上野股份有限公司	苯或噻吩衍生物及該等作為ｖａｐ－１抑制劑之用途
MX2011011757A (es) *	2009-05-04	2012-01-25	Prometic Biosciences Inc	Compuestos aromaticos substituidos y usos farmaceuticos.

2010
- 2010-01-29 AT AT0012210A patent/AT509045B1/de not_active IP Right Cessation
2011
- 2011-01-28 AU AU2011208939A patent/AU2011208939B2/en not_active Ceased
- 2011-01-28 JP JP2012550265A patent/JP5788907B2/ja not_active Expired - Fee Related
- 2011-01-28 EP EP15173989.3A patent/EP2965755A1/de not_active Withdrawn
- 2011-01-28 CN CN201510244522.0A patent/CN104958286B/zh not_active Expired - Fee Related
- 2011-01-28 KR KR1020127022355A patent/KR20120128644A/ko not_active Ceased
- 2011-01-28 EP EP11704168.1A patent/EP2528595B1/de not_active Not-in-force
- 2011-01-28 CN CN201180016552.6A patent/CN102858329B/zh not_active Expired - Fee Related
- 2011-01-28 CA CA2788326A patent/CA2788326A1/en not_active Abandoned
- 2011-01-28 WO PCT/AT2011/000050 patent/WO2011091461A1/de not_active Ceased
- 2011-01-28 US US13/578,516 patent/US20130065962A1/en not_active Abandoned
- 2011-01-28 MX MX2012008815A patent/MX2012008815A/es not_active Application Discontinuation
- 2011-01-28 BR BR112012018772A patent/BR112012018772A2/pt not_active IP Right Cessation
- 2011-01-28 SG SG2012056172A patent/SG182786A1/en unknown

Also Published As

Publication number	Publication date
CN104958286A (zh)	2015-10-07
EP2965755A1 (de)	2016-01-13
CN102858329B (zh)	2015-06-17
CN102858329A (zh)	2013-01-02
AT509045A4 (de)	2011-06-15
WO2011091461A1 (de)	2011-08-04
SG182786A1 (en)	2012-09-27
US20130065962A1 (en)	2013-03-14
AU2011208939A1 (en)	2012-08-30
AU2011208939B2 (en)	2015-07-09
CN104958286B (zh)	2018-01-05
CA2788326A1 (en)	2011-08-04
JP5788907B2 (ja)	2015-10-07
AT509045B1 (de)	2011-06-15
MX2012008815A (es)	2012-11-23
KR20120128644A (ko)	2012-11-27
JP2013518061A (ja)	2013-05-20
EP2528595A1 (de)	2012-12-05
EP2528595B1 (de)	2015-08-05

Legal Events

Date	Code	Title	Description
2016-11-29	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE A 6A ANUIDADE.
2017-03-14	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2395 DE 29-11-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

Publication	Publication Date	Title
BR112013008259A2 (pt)	2017-12-12	composto, composição farmacêutica, e, uso de um composto
BR112013015397A2 (pt)	2016-09-20	composto, composição farmacêutica, e, uso de um composto
BR112014001255A2 (pt)	2017-02-21	composto, uso de um composto, combinação, e, composição farmacêutica
BR112014013760A2 (pt)	2017-06-13	composto, composição farmacêutica e uso de um composto
BRPI1016219A2 (pt)	2016-04-26	composto, composição farmacêutica, e, uso de um composto
BRPI1008793A2 (pt)	2016-03-08	composto, uso de um composto, e, composição farmacêutica
BR112013011448A2 (pt)	2016-08-09	composto, composição farnmacêutica, e, uso do composto
BR112015000420A2 (pt)	2017-06-27	composto, composição farmacêutica, e, uso de um composto
BR112014005669A2 (pt)	2017-04-04	composto, composição farmacêutica e uso de um composto
BR112014003567A2 (pt)	2018-08-14	composto, uso de um composto, e, composição farmacêutica
BR112014029530A2 (pt)	2017-06-27	compostos, composição farmacêutica e uso de um composto
BRPI1007018A2 (pt)	2016-03-29	composto, composição farmacêutica, e , uso de um composto.
BR112014029115A2 (pt)	2017-06-27	composto, composição farmacêutica, e, uso de um composto ou composição
BRPI0919942A2 (pt)	2014-12-23	Composto, composição farmacêutica, e, uso de um composto
BRPI0907562A2 (pt)	2017-05-23	composto, composição farmacêutica, e, uso de um composto
BRPI0921375A2 (pt)	2015-12-29	composto, composição farmacêutica, e, uso de um composto
BRPI1008906A2 (pt)	2016-03-15	composto, composição farmacêutica, e, uso de um composto.
BR112012031226A2 (pt)	2018-03-06	composto, uso do composto, composição farmacêutica, e uso de composição farmacêutica
BR112013030302A2 (pt)	2017-06-27	composto, composição farmacêutica, uso de um composto, combinação de um composto e dispositivo
BRPI0917579A2 (pt)	2016-10-11	composto, composição farmacêutica, métodos, e, uso de um composto
BRPI0921879A2 (pt)	2018-10-16	composto, composição farmacêutica , e, uso de um composto
BRPI1009757A2 (pt)	2016-03-15	composto, composição farmacêutica, e , uso de um composto.
BR112014013178A2 (pt)	2017-06-13	composto, composição farmacêutica e uso de um composto
BRPI0906937A2 (pt)	2016-04-19	composto, composição farmacêutica, e, uso de um composto
BRPI1007186A2 (pt)	2016-02-23	composto, composição farmacêutica, e, uso de um composto